Lifesaving medicine withdrawn from the market. "A threat to patients"

The Chief Pharmaceutical Inspectorate has decided to retreat Corhydron 25, which is utilized to save lives in an emergency, for example during an anaphylactic shock. The review showed that the medicinal product does not meet the quality requirements. The concentration of the active substance may be life-threatening and healthy.